Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
Cigna's Express Scripts, one of the country's largest pharmacy benefit managers, today sued the Federal Trade Commission and ...
The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other ...
Learn more about Business Roundtable Mental Health Initiative here. About The Cigna Group The Cigna Group (NYSE:CI) is a ...
Cigna Group closed $8.47 below its 52-week high ($370.64), which the company reached on September 4th.
Jefferies analyst David Windley maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $422.00. The company’s shares closed yesterday at $366.85. According to ...